Results 1 to 10 of about 2,313 (193)

Safety and Effectiveness of Pharmacy Compounded Chenodeoxycholic Acid Capsules for Patients With Cerebrotendinous Xanthomatosis. [PDF]

open access: yesJ Inherit Metab Dis
ABSTRACT Chenodeoxycholic acid (CDCA) is an essential drug for patients with rare metabolic disease cerebrotendinous xanthomatosis (CTX). To ensure continuation of treatment, the Amsterdam UMC hospital pharmacy developed pharmacy compounded CDCA capsules when the authorized CDCA capsules were no longer available for Dutch patients.
Bouwhuis N   +9 more
europepmc   +2 more sources

Cerebrotendinous xanthomatosis: a treatable hereditary neuro-metabolic disease

open access: goldClinics, 2010
Ana Claudia Rodrigues de Cerqueira   +2 more
doaj   +2 more sources

Characterization of Postprandial Bile Acid Profiles and Glucose Metabolism in Cerebrotendinous Xanthomatosis. [PDF]

open access: yesNutrients, 2023
Majait S   +11 more
europepmc   +1 more source

Cerebrotendinous xanthomatosis: A report of 3 cases

open access: yesJAAD Case Reports, 2020
Katharine Saussy, MD   +2 more
doaj   +1 more source

Plasma sterol profiling in autism spectrum disorder: insights from cerebrotendinous xanthomatosis screening and beyond. [PDF]

open access: yesMetab Brain Dis
Calisgan K   +13 more
europepmc   +1 more source

Pathophysiology and Treatment of Lipid Abnormalities in Cerebrotendinous Xanthomatosis: An Integrative Review. [PDF]

open access: yesBrain Sci, 2023
Ribeiro RM   +14 more
europepmc   +1 more source

Clinical and genetic analysis of a family with cerebrotendinous xanthomatosis. [PDF]

open access: yesFront Neurol
Guoliang Y   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy